Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04218864 · ClinicalTrials.gov registry record · NA

Strength for U in Relationship Empowerment

A NA study of Mental Health and Perinatal, sponsored by Women and Infants Hospital of Rhode Island.

Completed
Registry status
NA
Development phase
122
Enrollment target
1
Study location

NCT04218864: Completed NA study of Mental Health and Perinatal, sponsored by Women and Infants Hospital of Rhode Island.

NCT04218864 is a NA study of Mental Health and Perinatal that has completed, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 122 participants, below the 10,181-participant average among 62 other Mental Health trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04218864, a NA study of Mental Health and Perinatal, has completed, sponsored by Women and Infants Hospital of Rhode Island.

COMPLETED
Registry status
NA
Development phase
122 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to test whether the innovative intervention, "Strength for U in Relationship Empowerment" (SURE), reduces the frequency of IPV more than an attention, time, and information matched control condition in perinatal women seeking mental health care.

Primary Outcome

The frequency of IPV will be measured using the Composite Abuse Scale. The Composite Abuse Scale is a 30-item scale with 4 subscales that measure severe combined abuse, emotional abuse, physical abuse, and harassment. Items are scored between 0 and 5, with Never=0 and Daily=5. Scale range is from 0-150. The lower the score, the better or less victimization. Change scores will be used to estimate differences within and between groups.

Interventions

  • BEHAVIORAL Strength for U in Relationship Empowerment (SURE)
  • BEHAVIORAL Attention, time, and information matched control

Study Locations (1)

Rhode Island

  • Women and Infants Hospital of Rhode Island - Providence

Trial Details

FieldValue
Enrollment Target 122 participants
Start Date 2020-01-02
Est. Completion 2024-02-09
Phase NA

What the finished NCT04218864 record still lists

NCT04218864 is an interventional study that assigns participants to a tested intervention. The registered 122 participants enrollment target is mid-sized for trials with a published cap, below the 10,181-participant average among 62 other Mental Health trials with a reported enrollment target (99% lower).

The record links to 3 conditions, with Mental Health appearing as the primary indexed condition, and to 2 interventions - of which Strength for U in Relationship Empowerment (SURE) is the first listed.

NCT04218864 reports a single indexed study location in Rhode Island.

Frequently Asked Questions

What is clinical trial NCT04218864 about?

NCT04218864 is a clinical study titled "Strength for U in Relationship Empowerment". The objective of this study is to test whether the innovative intervention, "Strength for U in Relationship Empowerment" (SURE), reduces the frequency of IPV more than an attention, time, and information matched control condition in perinatal women seeking mental health care.

What is the current status of trial NCT04218864?

This trial is currently completed. It is a NA study. The enrollment target is 122 participants. The study started on 2020-01-02. Estimated completion is 2024-02-09.

What conditions does trial NCT04218864 study?

This clinical trial studies the following conditions: Mental Health, Perinatal, IPV.

What interventions are being tested in trial NCT04218864?

The interventions under investigation include: Strength for U in Relationship Empowerment (SURE) (BEHAVIORAL), Attention, time, and information matched control (BEHAVIORAL).

Who is sponsoring clinical trial NCT04218864?

This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04218864 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mental Health

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04218864's enrollment target sits among peer trials

122 41st of 62 higher than 22 of 62 other Mental Health trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mental Health trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03363373 · 122 participants · Phase 2

    Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow

  • NCT03463954 · 122 participants · NA

    Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors

  • NCT04503265 · 122 participants · Phase 1

    A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

  • NCT04700527 · 122 participants · Phase 1

    The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04218864, the US trial registry maintained by the National Library of Medicine. NCT04218864 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.